--- title: "Melanoma Follow Up R3767-ONC-2466 | Sutter Health" description: "Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613" url: "https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Research studies](https://www.sutterhealth.org/research/studies) / 4. Melanoma Follow Up R3767-ONC-2466 # Melanoma Follow Up R3767-ONC-2466 ****TEMPORARILY CLOSED TO ENROLLMENT**** This study is researching the long-term effects of a combination of experimental drugs called fianlimab and cemiplimab. The study is being conducted in patients with advanced skin cancer (melanoma) who had previously been treated with fianlimab and cemiplimab in the study called R3767-ONC-1613 (NCT03005782). ![Kevin B Kim, M.D.](https://dyn.mktgcdn.com/p/c5YP2PezO8WGhQo-AyMNM4jgZenkBbfA9R6zjGEliTY/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Kevin B Kim, M.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/kevin-b-kim-md-1049681162) ## Research topics - [Skin Cancer/Melanoma](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Skin+Cancer%2FMelanoma%5C%22%22) - [All Cancer](https://www.sutterhealth.org/research-search-results?query=%22%5C%22All+Cancer%5C%22%22) ## Related studies [View all studies](https://www.sutterhealth.org/research/studies) - Research study ### [Melanoma DECIDE](https://www.sutterhealth.org/research/studies/melanoma-castle-decide-1049141954) DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes - Research study ### [Bone Marrow Transplant Database](https://www.sutterhealth.org/research/studies/bone-marrow-transplant-1049141785) Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries - Research study ### [Cancer Liquid Biopsy Monitoring Study](https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806) A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung cancer. - Research study ### [Adjuvant Advanced Cervical Cancer GY037](https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140) A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer - Research study ### [Ductal Carcinoma In Situ (DCIS) Registry Dana Farber](https://www.sutterhealth.org/research/studies/dana-farber-13-09-259-dcis-1049141920) Molecular Characterization of Breast Cancer with Duct Forming Features [View all studies](https://www.sutterhealth.org/research/studies) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research studies","item":"https://www.sutterhealth.org/research/studies"},{"@type":"ListItem","position":4,"name":"Melanoma Follow Up R3767-ONC-2466"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020#medicalwebpage","name":"Melanoma Follow Up R3767-ONC-2466","description":"Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613","url":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020","inLanguage":"en-US","dateModified":"2026-07-17","publisher":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"medicalAudience":{"@type":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020#medicalobservationalstudy"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020#breadcrumblist"},"mentions":[{"@type":"Person","@id":"https://www.sutterhealth.org/find-provider/dr-kevin-b-kim-1046238722#Person","name":"Kevin B Kim, M.D.","url":"https://www.sutterhealth.org/research/investigators/kevin-b-kim-md-1049681162","sameAs":"https://www.sutterhealth.org/find-provider/dr-kevin-b-kim-1046238722"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalObservationalStudy","@id":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020#medicalobservationalstudy","name":"Melanoma Follow Up R3767-ONC-2466","alternateName":"Melanoma Follow Up R3767-ONC-2466","url":"https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020","description":"TEMPORARILY CLOSED TO ENROLLMENT This study is researching the long-term effects of a combination of experimental drugs called fianlimab and cemiplimab. The study is being conducted in patients with advanced skin cancer (melanoma) who had previously been treated with fianlimab and cemiplimab in the study called R3767-ONC-1613 (NCT03005782).","healthCondition":[{"@type":"MedicalCondition","name":"Skin Cancer/Melanoma"},{"@type":"MedicalCondition","name":"All Cancer"}]} ```